Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Молекулярно-биологические факторы прогноза при В-клеточном хроническом лимфолейкозе
Молекулярно-биологические факторы прогноза при В-клеточном хроническом лимфолейкозе
Е.А. Никитин, С.Г. Малахо, Б.В. Бидерман, А.Б. Полтараус, А.Б. Судариков. Молекулярно-биологические факторы прогноза при В-клеточном хроническом лимфолейкозе. Онкология. 2006; 1: 30-33.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Fais F et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 1515–25.
2. Damle RN et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–7.
3. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–54.
4. Krober G et.al. Multivariate survival analysis of specific VH-genes in CLL: VH3-21 and VH3-23 are prognosic factors independently of the VH mutation status (abstract). Blood 2002; 100: 196a.
5. Tobin G et.al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004; 104: 2878–85.
6. Rosenwald A et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–47.
7. Klein U et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001; 194: 1625–38.
8. Haslinger C, Schweifer N, Stilgenbauer S et.al. Microarray gene expression profiling of B-cell Chronic lymphocytic leukemia subgroups defined by gnomic aberrations and VH mutation status. J Clin Oncol 2004; 22: 3937–49.
9. Tobin G et.al. V(H)3-21 gene usage in chronic lymphocytic leukemia: characterization of a new subgroup with distinct molecular features and poor survival Leuk. Lymphoma 2004; 45: 221–8.
2. Damle RN et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–7.
3. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–54.
4. Krober G et.al. Multivariate survival analysis of specific VH-genes in CLL: VH3-21 and VH3-23 are prognosic factors independently of the VH mutation status (abstract). Blood 2002; 100: 196a.
5. Tobin G et.al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004; 104: 2878–85.
6. Rosenwald A et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–47.
7. Klein U et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001; 194: 1625–38.
8. Haslinger C, Schweifer N, Stilgenbauer S et.al. Microarray gene expression profiling of B-cell Chronic lymphocytic leukemia subgroups defined by gnomic aberrations and VH mutation status. J Clin Oncol 2004; 22: 3937–49.
9. Tobin G et.al. V(H)3-21 gene usage in chronic lymphocytic leukemia: characterization of a new subgroup with distinct molecular features and poor survival Leuk. Lymphoma 2004; 45: 221–8.
Авторы
Е.А. Никитин, С.Г. Малахо, Б.В. Бидерман, А.Б. Полтараус, А.Б. Судариков
Гематологический научный центр РАМН
Институт молекулярной биологии им. Энгельгардта РАН, Москва
Гематологический научный центр РАМН
Институт молекулярной биологии им. Энгельгардта РАН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.